Pure Bioscience Inc (PURE)
| Sector • Basic Materials Industry • Chemical Manufacturing |
| Industry • Chemical Manufacturing |
| Sector • Basic Materials |
Inconsequential dip in the Top-line at Pure Bioscience Inc all along the second quarter of 2023
Pure Bioscience Inc announced second quarter of 2023 operating shortfall of $-1.058 millions
Published Mar 25 2023
Goran Soko / CSIMarket.com Contributer
![ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common](../news/img/chemical/ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common.jpg "ShellMartinez-refi_User.Leonard_G_ _[CC-BY-SA-1.0_(http_creativecommons.org_licenses_by-sa_1.0)]_via_Wikimedia_Common")
For the fiscal interval ending January 31 2023 Pure Bioscience Inc lost money of $-0.01 per share compare to $-0.01 a year ago and from $-0.01 per share from the previous reporting season. Revenues contracted by -4.567 % to $0.40 millions from $0.42 millions in the similar reporting season a year ago and sequentially Revenues fell by -15.711 % from $0.47 millions.
For the fiscal interval ending January 31 2023 Pure Bioscience Inc realized net shortfall of $-1.060 million, bigger than $-0.702 million a year ago.
Pure Bioscience Inc is expected to report next financial earnings on June 13, 2023.
Other PURE's Earnings Reports
Revenues receded by -5.988 %, at PURE in the most recent fiscal period
Other PURE's Earnings Reports
Revenues receded by -5.988 %, at PURE in the most recent fiscal period